TrademarkDir
ALOPRIN
LIVE

Serial Number

90043059

Owner

AMERICAN GLOBAL HEALTH GROUP, LLC.

Attorney

Raj Abhyanker

Filing Date

Jul 9, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ALOPRIN Trademark

Serial Number: 90043059 • Registration: 6702308

ALOPRIN is a trademark filed by AMERICAN GLOBAL HEALTH GROUP, LLC. on July 9, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

AMERICAN GLOBAL HEALTH GROUP, LLC.

11335 NE 122nd Way
Kirkland, WA 98034

Entity Type: 16

Trademark Details

Filing Date

July 9, 2020

Registration Date

April 12, 2022

Published for Opposition

December 1, 2020

Goods & Services

Dry and liquid aloe vera raw material in the nature of aloe vera prepared for human consumption sold as a component ingredient of dietary supplements, liquid based dietary supplements, and aloe-based drinks being dietary supplemental drinks, all the foregoing made in significant part of aloe

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2026 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 19, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 19, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 19, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 19, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 19, 2026 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 14, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 14, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 14, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 14, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Apr 12, 2022 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 26, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 26, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 26, 2022 REAP
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 8, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 6, 2022 CNPR
ASSIGNED TO EXAMINER
Jan 24, 2022 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Jan 18, 2022 SUPC
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 2, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 2, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 2, 2021 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 2, 2021 EXRA
SOU EXTENSION 1 GRANTED
Nov 1, 2021 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 1, 2021 AITU
USE AMENDMENT FILED
Oct 13, 2021 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 13, 2021 EISU
NOTICE OF REVIVAL - E-MAILED
Oct 13, 2021 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Oct 13, 2021 TPEX
PETITION TO REVIVE-GRANTED
Oct 13, 2021 PETG
TEAS PETITION TO REVIVE RECEIVED
Oct 13, 2021 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 30, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 30, 2021 ABN6
SOU EXTENSION 1 FILED
Jul 26, 2021 EXT1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 17, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 17, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 17, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 17, 2021 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 26, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 1, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 1, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 11, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 23, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 23, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 23, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 23, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 23, 2020 CNEA
ASSIGNED TO EXAMINER
Oct 20, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2020 NWOS
NEW APPLICATION ENTERED
Jul 13, 2020 NWAP

Related Trademarks

More from this Owner

ALOECURE

ALOECURE

ALOECURE

ALOECURE

ALOPRIN

ALOPRIN

ALOPRIN

ALOPRIN

ALOPRIN

ALOPRIN